[
  {
    "variant_id": {
      "Gene": "SNCA",
      "Protein_Change": {
        "ref": "A",
        "alt": "P",
        "position": "30"
      },
      "variant_string_id": "SNCA A30P"
    },
    "functional_evidence_aim": "Pathogenic",
    "assessment_steps": [
      {
        "step_name": "Step 1: Define the disease mechanism",
        "extracted_paper_info": "The A30P mutant is known to cause early-onset Parkinson's disease.",
        "judgment": "Yes",
        "reasoning": "The paper clearly states that the A30P mutation causes Parkinson's disease, indicating the variant is potentially pathogenic."
      },
      {
        "step_name": "Step 2: Evaluate applicability of general classes of assay used in the field",
        "extracted_paper_info": "The authors used single-molecule FRET (smFRET) to study the conformational dynamics of alpha-synuclein proteins with A30P mutation.",
        "judgment": "Yes",
        "reasoning": "smFRET is a well-established technique in the field of protein conformational dynamics, suggesting its applicability for assessing functional aspects of the A30P mutation.",
        "next_step_or_outcome": "Proceed to Step 3"
      },
      {
        "step_name": "Step 3: Evaluate validity of specific instances of assays",
        "sub_steps": [
          {
            "step_name": "Sub-step 3a: Basic Controls and Replicates",
            "extracted_paper_info": "The authors included wild-type (WT) alpha-synuclein as a negative control and performed three independent replicates.",
            "judgment": "Yes",
            "reasoning": "Both negative control (WT) and replicates (n=3) were used, satisfying the requirements for basic controls and replicates."
          },
          {
            "step_name": "Sub-step 3c: Variant Controls",
            "extracted_paper_info": "The authors compared the conformational dynamics of A30P mutant with WT alpha-synuclein, which is known to be pathogenic.",
            "judgment": "Yes",
            "reasoning": "The use of known pathogenic control (WT) satisfies the requirement for variant controls."
          }
        ],
        "next_step_or_outcome": "Proceed to Step 4"
      },
      {
        "step_name": "Step 4: Apply evidence to individual variant interpretation",
        "sub_steps": [
          {
            "step_name": "Sub-step 4a: Statistical Analyses",
            "extracted_paper_info": "The authors did not provide specific statistical analyses or OddsPath calculations.",
            "judgment": "No",
            "reasoning": "Due to the lack of statistical analyses, we cannot determine the OddsPath for the A30P mutation.",
            "next_step_or_outcome": "Proceed to Sub-step 4b"
          },
          {
            "step_name": "Sub-step 4b: No OddsPath Calculation",
            "extracted_paper_info": "The authors included one known pathogenic control (WT), which satisfies the requirement for variant controls.",
            "judgment": "Yes",
            "reasoning": "With only one known pathogenic control, the maximum strength of functional evidence is PS3_supporting.",
            "final_evidence_strength": {
              "type": "Pathogenic",
              "strength": "PS3_supporting"
            }
          }
        ]
      }
    ],
    "final_evidence_strength": {
      "type": "Pathogenic",
      "strength": "PS3_supporting"
    },
    "overall_conclusion": "Based on the provided information, the functional evidence suggests that the A30P mutation is likely pathogenic (PS3_supporting). However, the lack of statistical analyses and limited number of controls prevents a stronger assessment."
  }
]